Novel Potent Antimitotic Heterocyclic Ketones: Synthesis, Antiproliferative Activity, and Structure—Activity Relationships.
Laixing Hu(Georgia State University), David W. Boykin(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinrong Qu(Memorial Sloan Kettering Cancer Center), Jian‐Dong Jiang(Ningbo University), Zhuorong Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Li(Georgia State University), Jie Jin(Jiangsu University)
Cited by 0
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
|Metabolism|2008|265